LINAGLIPTIN HYDROXYETHYLPHTHALIMIDE ANALOG

UNII:	2C6YGZ385D
Type:	INGREDIENT SUBSTANCE
Formula:	C₃₅H₃₇N₉O₅
Preferred Substance Name:	LINAGLIPTIN HYDROXYETHYLPHTHALIMIDE ANALOG
InChIKey:	ZFNQEMCRVBLZQE-HSZRJFAPSA-N
GSRS Full Record:	2C6YGZ385D i

2074688-80-3
(R)-N1-{1-[7-(But-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl]piperidin-3-yl}-N2-(2-hydroxyethyl)phthalamide [IUPAC]
1,2-Benzenedicarboxamide, N1-[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-N2-(2-hydroxyethyl)- [INDEX-NAME]
Linagliptin Hydroxyethylphthalimide Analog
Linagliptin Hydroxyethylphthalimide Analog [USP Nickname]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LINAGLIPTIN HYDROXYETHYLPHTHALIMIDE ANALOG

Synonyms and Mappings

Resources